Article info
PDFHepatology
Original research
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes
- Correspondence to Professor Thomas Reiberger, Clinical Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; thomas.reiberger{at}meduniwien.ac.at
Citation
Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes
Publication history
- Received August 3, 2020
- Revised October 18, 2020
- Accepted October 19, 2020
- First published November 16, 2020.
Online issue publication
August 06, 2021
Article Versions
- Previous version (16 November 2020).
- Previous version (15 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.